| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1462399404007604 |
| P698 | PubMed publication ID | 15061872 |
| P2093 | author name string | Barry T Rouse | |
| Kaustuv Banerjee | |||
| Partha Sarathi Biswas | |||
| Shilpa Deshpande | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1-14 | |
| P577 | publication date | 2004-03-30 | |
| P1433 | published in | Expert Reviews in Molecular Medicine | Q15755244 |
| P1476 | title | Herpetic eye disease: immunopathogenesis and therapeutic measures | |
| P478 | volume | 6 |
| Q34248602 | A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis |
| Q39892107 | A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent |
| Q47554197 | Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy |
| Q37605818 | Clinical evaluation of deep anterior lamellar keratoplasty using glycerol-cryopreserved corneal tissues for refractory herpetic stromal keratitis: An observational study |
| Q37466085 | Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1 |
| Q37161210 | Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. |
| Q34102743 | Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling |
| Q37940579 | Delayed type hypersensitivity in the pathogenesis of recurrent herpes stromal keratitis |
| Q40171791 | Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology |
| Q39239092 | Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye. |
| Q36205873 | Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner |
| Q36063082 | Inhibition of HSV-1 by chemoattracted neutrophils: supernatants of corneal epithelial cells (HCE) and macrophages (THP-1) treated with virus components chemoattract neutrophils (PMN), and supernatants of PMN treated with these conditioned media inhi |
| Q36099335 | Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis |
| Q83654097 | Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease |
| Q37600490 | Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy |
| Q37181670 | Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology |
| Q36569374 | Neutrophil in viral infections, friend or foe? |
| Q37070498 | Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis |
| Q57476625 | Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation |
| Q36563550 | Regulatory T cells in virus infections |
| Q33912065 | Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis |
| Q41966343 | Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses |
| Q35526765 | Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions |
| Q36259475 | The role of bystander T cells in CNS pathology and pathogen clearance |
Search more.